← The Wire
NPCENasdaq
NeuroPace Inc
Surgical & Medical Instruments & Apparatus · DE · CIK 1528287
NeuroPace Inc develops a brain-responsive neuromodulation system to prevent seizures in epilepsy patients
$533M
Market cap
$16.53
Last close
+0.4%
1D
+7.5%
5D
161K
Volume
Price · last 39 sessions-2.2%
May 4L $15.02 · H $19.29Jun 29
92
Total filings
Jun 8, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 8, 202610-Q10-QMay 12, 20268-KResults of OperationsMay 12, 2026DEFA14ADEFA14AApr 21, 2026DEF 14ADEF 14AApr 21, 202610-K10-KMar 3, 20268-KResults of OperationsMar 3, 202610-Q10-QNov 4, 20258-KResults of OperationsNov 4, 202510-Q10-QAug 12, 20258-KResults of OperationsAug 12, 20258-KExecutive Change · Reg FD DisclosureJun 24, 20258-KShareholder VoteJun 12, 20258-KMaterial Agreement · Agreement TerminatedJun 4, 20258-KReg FD Disclosure · Company UpdateMay 27, 202510-Q10-QMay 13, 20258-KResults of OperationsMay 13, 2025DEFA14ADEFA14AApr 22, 2025DEF 14ADEF 14AApr 22, 20258-KReg FD DisclosureApr 14, 20258-KReg FD Disclosure · Company UpdateApr 2, 202510-K10-KMar 4, 20258-KResults of OperationsMar 4, 20258-KReg FD Disclosure · Company UpdateFeb 20, 20258-KCompany UpdateFeb 18, 2025424B5424B5Feb 18, 20258-KMaterial AgreementFeb 14, 2025424B5424B5Feb 14, 20258-KResults of Operations · Reg FD DisclosureJan 28, 20258-KReg FD DisclosureJan 15, 20258-KExecutive Change · Results of OperationsJan 8, 202510-Q10-QNov 12, 20248-KResults of OperationsNov 12, 202410-Q10-QAug 13, 20248-KResults of OperationsAug 13, 20248-KShareholder VoteJun 10, 202410-Q10-QMay 8, 20248-KResults of OperationsMay 8, 2024DEFA14ADEFA14AApr 22, 2024DEF 14ADEF 14AApr 22, 202410-K10-KMar 5, 20248-KResults of OperationsMar 5, 20248-KExecutive ChangeFeb 7, 20248-KResults of Operations · Reg FD DisclosureJan 8, 20248-KMaterial AgreementDec 4, 202310-Q10-QNov 6, 20238-KResults of OperationsNov 6, 202310-Q10-QAug 8, 20238-KResults of OperationsAug 8, 20238-KExecutive ChangeJul 19, 20238-KExecutive ChangeJun 28, 20238-KShareholder VoteJun 12, 202310-Q10-QMay 4, 20238-KResults of OperationsMay 4, 2023DEFA14ADEFA14AApr 25, 2023DEF 14ADEF 14AApr 25, 20238-KExecutive ChangeApr 13, 202310-K10-KMar 2, 20238-KResults of OperationsMar 2, 2023SC 13GMS INITIALFeb 10, 2023SC 13GSC 13GFeb 9, 20238-KExecutive Change · Results of OperationsJan 9, 2023SC 13DSC 13DNov 21, 202210-Q10-QNov 8, 20228-KResults of OperationsNov 8, 2022SC 13GSC 13GOct 7, 202210-Q10-QAug 11, 20228-KMaterial Agreement · Results of OperationsAug 11, 20228-KShareholder VoteJun 17, 202210-Q10-QMay 12, 20228-KResults of OperationsMay 12, 2022DEFA14ADEFA14AApr 22, 2022DEF 14ADEF 14AApr 22, 202210-K10-KMar 10, 20228-KResults of OperationsMar 10, 2022SC 13GSC 13GJan 13, 20228-KResults of Operations · Reg FD DisclosureJan 11, 202210-Q10-QNov 10, 20218-KResults of OperationsNov 10, 2021SC 13GSC 13GNov 1, 2021
Insider Activity
In the 90 days to Dec 15, 2025: 1 sold $399K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 15, 2025 | Morrell MarthaCHIEF MEDICAL OFFICER | Sell | 25,000 | $15.97 | $399K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance